173 related articles for article (PubMed ID: 26334619)
1. Anti-proliferative and anti-invasive effects of ferulic acid in TT medullary thyroid cancer cells interacting with URG4/URGCP.
Dodurga Y; Eroğlu C; Seçme M; Elmas L; Avcı ÇB; Şatıroğlu-Tufan NL
Tumour Biol; 2016 Feb; 37(2):1933-40. PubMed ID: 26334619
[TBL] [Abstract][Full Text] [Related]
2. Ferulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro.
Fahrioğlu U; Dodurga Y; Elmas L; Seçme M
Gene; 2016 Jan; 576(1 Pt 3):476-82. PubMed ID: 26516023
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines.
Eroğlu C; Seçme M; Bağcı G; Dodurga Y
Tumour Biol; 2015 Dec; 36(12):9437-46. PubMed ID: 26124008
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide may induce cell cycle arrest by interacting with URG4/URGCP in SH-SY5Y neuroblastoma cells.
Çıtışlı V; Dodurga Y; Eroğlu C; Seçme M; Avcı ÇB; Şatıroğlu-Tufan NL
Tumour Biol; 2015 Sep; 36(9):6765-72. PubMed ID: 25835972
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.
Dodurga Y; Gundogdu G; Tekin V; Koc T; Satiroglu-Tufan NL; Bagci G; Kucukatay V
Mol Biol Rep; 2014 Jul; 41(7):4595-9. PubMed ID: 24652203
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the effects of a sulfite molecule on human neuroblastoma cells via a novel oncogene URG4/URGCP.
Dodurga Y; Seçme M; Eroğlu C; Gündoğdu G; Avcı ÇB; Bağcı G; Küçükatay V; Lale Şatıroğlu-Tufan N
Life Sci; 2015 Dec; 143():27-34. PubMed ID: 26506573
[TBL] [Abstract][Full Text] [Related]
7. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
[TBL] [Abstract][Full Text] [Related]
8. Investigation of microRNA expression changes in HepG2 cell line in presence of URG4/URGCP and in absence of URG4/URGCP suppressed by RNA interference.
Dodurga Y; Yonguc GN; Avci CB; Bagci G; Gunduz C; Satiroglu-Tufan NL
Mol Biol Rep; 2012 Dec; 39(12):11119-24. PubMed ID: 23053999
[TBL] [Abstract][Full Text] [Related]
9. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
[TBL] [Abstract][Full Text] [Related]
10. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
11. A novel oncogene URG4/URGCP and its role in cancer.
Dodurga Y; Seçme M; Lale Şatıroğlu-Tufan N
Gene; 2018 Aug; 668():12-17. PubMed ID: 29775749
[TBL] [Abstract][Full Text] [Related]
12. Expression of URG4/URGCP, Cyclin D1, Bcl-2, and Bax genes in retinoic acid treated SH-SY5Y human neuroblastoma cells.
Dodurga Y; Gundogdu G; Koc T; Yonguc GN; Kucukatay V; Satiroglu-Tufan NL
Contemp Oncol (Pozn); 2013; 17(4):346-9. PubMed ID: 24592121
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic exendin-4 activates apoptotic pathway and inhibits growth of breast cancer cells.
Fidan-Yaylalı G; Dodurga Y; Seçme M; Elmas L
Tumour Biol; 2016 Feb; 37(2):2647-53. PubMed ID: 26399993
[TBL] [Abstract][Full Text] [Related]
14. Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.
Tesfazghi S; Eide J; Dammalapati A; Korlesky C; Wyche TP; Bugni TS; Chen H; Jaskula-Sztul R
Cancer Med; 2013 Oct; 2(5):734-43. PubMed ID: 24403239
[TBL] [Abstract][Full Text] [Related]
15. Investigation of anticancer mechanism of oleuropein via cell cycle and apoptotic pathways in SH-SY5Y neuroblastoma cells.
Seçme M; Eroğlu C; Dodurga Y; Bağcı G
Gene; 2016 Jul; 585(1):93-99. PubMed ID: 27032461
[TBL] [Abstract][Full Text] [Related]
16. URG4-silencing suppresses cell proliferation in nasopharyngeal carcinoma through induction of apoptosis.
Luo XY; Yan B; Cai CF; Chen AM; Zhou M
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1717-1725. PubMed ID: 29630117
[TBL] [Abstract][Full Text] [Related]
17. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells.
Du ZX; Zhang HY; Gao DX; Wang HQ; Li YJ; Liu GL
Exp Mol Med; 2006 Jun; 38(3):230-40. PubMed ID: 16819281
[TBL] [Abstract][Full Text] [Related]
18. Salidroside inhibits migration and invasion of poorly differentiated thyroid cancer cells.
Shang H; Wang S; Yao J; Guo C; Dong J; Liao L
Thorac Cancer; 2019 Jun; 10(6):1469-1478. PubMed ID: 31120636
[TBL] [Abstract][Full Text] [Related]
19. Regulation of URG4/URGCP and PPARα gene expressions after retinoic acid treatment in neuroblastoma cells.
Avci CB; Dodurga Y; Gundogdu G; Caglar HO; Kucukatay V; Gunduz C; Satiroglu-Tufan NL
Tumour Biol; 2013 Dec; 34(6):3853-7. PubMed ID: 23821302
[TBL] [Abstract][Full Text] [Related]
20. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
